PubMed:2041591 JSONTXT

{"project":"bionlp-st-epi-2011-training","denotations":[{"id":"T1","span":{"begin":130,"end":149},"obj":"Protein"}],"text":"Xenobiotic enzyme profiles and Parkinson's disease.\nXenobiotic enzymic systems have been studied in Parkinson's disease. Platelet monoamine oxidase-B activity is increased by the use of phenylethylamine but decreased by the use of dopamine as substrate. Enzymes involved with sulfur oxidation and methylation are underactive."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":100,"end":109},"obj":"HP_0001300"}],"text":"Xenobiotic enzyme profiles and Parkinson's disease.\nXenobiotic enzymic systems have been studied in Parkinson's disease. Platelet monoamine oxidase-B activity is increased by the use of phenylethylamine but decreased by the use of dopamine as substrate. Enzymes involved with sulfur oxidation and methylation are underactive."}